Vista Pharmaceuticals Ltd.
BSE: 524711
₹7.00
₹-0.39
(-5.28%)
As on 10-Jun-2026 11:02IST
Market cap
₹45 Cr
Revenue (TTM)
₹5 Cr
P/E Ratio
--
P/B Ratio
1.2
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-12 Cr
-
ROE
-11.5 %
-
ROCE
-8.5 %
-
Industry P/E
44.6
-
EV/EBITDA
-3.9
-
Debt to Equity
0.1
-
Book Value
₹5.9
-
EPS
₹-2
-
Face value
2
-
Shares outstanding
61,551,907
10 Years Aggregate
CFO
₹-21.76 Cr
EBITDA
₹-7.46 Cr
Net Profit
₹-16.25 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Vista Pharma
| -14.0 | -5.8 | 14.9 | -40.9 | -10.9 | -9.2 | -8.3 |
|
BSE Healthcare
| 9.4 | 2.1 | 9.5 | 9.2 | 25.2 | 13.8 | 12.3 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Vista Pharma
| -31.0 | -23.5 | 24.5 | 14.0 | 1.3 | 1.7 | -66.0 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Vista Pharma
|
7.0 | 45.5 | 5.4 | -12.1 | -284.6 | -29.8 | -- | 1.2 |
| 3,264.6 | 26,188.5 | 1,339.4 | 356.4 | 33.2 | 23.2 | 73.5 | 15.8 | |
| 435.4 | 16,515.4 | 2,268.6 | 150.1 | 10.6 | 5.4 | 92.1 | 4.2 | |
| 773.0 | 18,955.2 | 5,365.6 | 595.0 | 16.6 | 13.3 | 31.9 | 3.7 | |
| 966.5 | 15,441.5 | 8,279.6 | 397.8 | 9.9 | 6.4 | 38.7 | 2.2 | |
| 864.0 | 15,502.9 | 4,078.3 | 1,371.9 | 30.2 | 15.9 | 10.9 | 1.7 | |
| 1,678.4 | 19,654.3 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.4 | |
| 169.2 | 22,479.8 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.8 | |
| 455.1 | 17,939.1 | 3,738.7 | 316.7 | 12.5 | 7.5 | 56.6 | 3.7 | |
| 1,880.9 | 30,663.1 | 3,373.0 | 199.0 | 12.6 | 5.9 | 144 | 6.2 |
Shareholding Pattern
View DetailsNews & Analysis
All News
1 min read•By Research Desk
About Vista Pharma
Vista Pharmaceuticals Limited manufactures and sells pharmaceutical, medical, and veterinary preparations in India, the United States, and internationally. It offers over the counter and prescription generic drugs consisting of tablets, capsules, and... liquids covering various therapeutic categories. Vista Pharmaceuticals Limited was incorporated in 1991 and is based in Hyderabad, India. Read more
-
Incorporated
1991
-
Chairman
Dhananjaya Alli
-
Managing Director
Murali Meraga
-
Headquarters
Nalgonda Dist, Telangana
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsNo News & Announcements are available.
FAQs for Vista Pharma
What is the current share price of Vista Pharmaceuticals Ltd Today?
The share price of Vista Pharmaceuticals Ltd is ₹7.00 (BSE) as of 10-Jun-2026 11:02 IST. Vista Pharmaceuticals Ltd has given a return of -10.94% in the last 3 years.
What is the current PB & PE ratio of Vista Pharmaceuticals Ltd?
Since, TTM earnings of Vista Pharmaceuticals Ltd is negative, P/E ratio is not available.
The P/B ratio of Vista Pharmaceuticals Ltd is 1.25 times as on 09-Jun-2026, a 66 discount to its peers’ median range of 3.73 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
1.46
|
|
2024
|
0.00
|
1.41
|
|
2023
|
0.00
|
1.03
|
|
2022
|
0.00
|
0.96
|
|
2021
|
0.00
|
1.01
|
What is the 52 Week High and Low of Vista Pharmaceuticals Ltd?
The 52-week high and low of Vista Pharmaceuticals Ltd are Rs 11.87 and Rs 5.71 as of 10-Jun-2026.
What is the market cap of Vista Pharmaceuticals Ltd?
Vista Pharmaceuticals Ltd has a market capitalisation of ₹ 45 Cr as on 09-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Vista Pharmaceuticals Ltd?
Before investing in Vista Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.